AGIOS PHARMACEUTICALS, INC. Cost of Revenue
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Cost of Revenue of $3.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $3.00M, a 76.03% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $1.32M, a 21.57% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $1.88M, a 49.13% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $1.68M, a 114.43% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2025 was $6.34M, a 52.34% increase from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2024 was $4.17M, a 44.57% increase from fiscal 2023.
- AGIOS PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2023 was $2.88M, a 69.07% increase from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. cost of goods and services sold for fiscal 2022 was $1.70M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $3.00M 10-Q · filed 2026-07-30 | $4.32M 10-Q · filed 2026-07-30 | $6.19M derived: sum of 3 quarters · filed 2026-07-30 | $7.87M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $1.32M 10-Q · filed 2026-04-29 | $3.20M derived: sum of 2 quarters · filed 2026-04-29 | $4.88M derived: sum of 3 quarters · filed 2026-04-29 | $6.58M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $3.56M derived: sum of 2 quarters · filed 2026-02-12 | $5.26M derived: sum of 3 quarters · filed 2026-07-30 | $6.34M 10-K · filed 2026-02-12 | |
| 2025-09-30 | $1.68M 10-Q · filed 2025-10-30 | $3.38M derived: sum of 2 quarters · filed 2026-07-30 | $4.47M 10-Q · filed 2025-10-30 | $5.73M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $1.70M 10-Q · filed 2026-07-30 | $2.79M 10-Q · filed 2026-07-30 | $4.05M derived: sum of 3 quarters · filed 2026-07-30 | $4.83M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $1.08M 10-Q · filed 2026-04-29 | $2.35M derived: sum of 2 quarters · filed 2026-04-29 | $3.13M derived: sum of 3 quarters · filed 2026-04-29 | $4.62M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2024-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $2.04M derived: sum of 2 quarters · filed 2026-02-12 | $3.54M derived: sum of 3 quarters · filed 2026-02-12 | $4.17M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $783.00K 10-Q · filed 2025-10-30 | $2.28M derived: sum of 2 quarters · filed 2025-10-30 | $2.90M 10-Q · filed 2025-10-30 | $3.49M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-06-30 | $1.50M 10-Q · filed 2025-07-31 | $2.12M 10-Q · filed 2025-07-31 | $2.71M derived: sum of 3 quarters · filed 2026-02-12 | $3.34M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-03-31 | $627.00K 10-Q · filed 2025-05-01 | $1.21M derived: sum of 2 quarters · filed 2026-02-12 | $1.85M derived: sum of 3 quarters · filed 2026-02-12 | $2.95M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2023-12-31 | $586.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.22M derived: sum of 2 quarters · filed 2026-02-12 | $2.33M derived: sum of 3 quarters · filed 2026-02-12 | $2.88M 10-K · filed 2026-02-12 | |
| 2023-09-30 | $633.00K 10-Q · filed 2024-10-31 | $1.74M derived: sum of 2 quarters · filed 2024-10-31 | $2.29M 10-Q · filed 2024-10-31 | $2.71M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-06-30 | $1.11M 10-Q · filed 2024-08-01 | $1.66M 10-Q · filed 2024-08-01 | $2.08M derived: sum of 3 quarters · filed 2025-02-13 | $2.59M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-03-31 | $554.00K 10-Q · filed 2024-05-02 | $967.00K derived: sum of 2 quarters · filed 2025-02-13 | $1.48M derived: sum of 3 quarters · filed 2025-02-13 | $1.92M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2022-12-31 | $413.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $930.00K derived: sum of 2 quarters · filed 2025-02-13 | $1.36M derived: sum of 3 quarters · filed 2025-02-13 | $1.70M 10-K · filed 2025-02-13 | |
| 2022-09-30 | $517.00K 10-Q · filed 2023-11-02 | $952.00K derived: sum of 2 quarters · filed 2023-11-02 | $1.29M 10-Q · filed 2023-11-02 | $1.29M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-06-30 | $435.00K 10-Q · filed 2023-08-03 | $774.00K 10-Q · filed 2023-08-03 | $774.00K derived: sum of 3 quarters · filed 2024-02-15 | $774.00K derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-03-31 | $339.00K 10-Q · filed 2023-05-04 | $339.00K derived: sum of 2 quarters · filed 2024-02-15 | $339.00K derived: sum of 3 quarters · filed 2024-02-15 | $339.00K derived: sum of 4 quarters · filed 2024-02-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $0.00 derived: sum of 2 quarters · filed 2024-02-15 | $0.00 derived: sum of 3 quarters · filed 2024-02-15 | $0.00 10-K · filed 2024-02-15 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | -$1.85M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | -$1.85M derived: sum of 3 quarters · filed 2023-02-23 | -$1.21M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | -$1.85M derived: sum of 2 quarters · filed 2023-02-23 | -$1.21M derived: sum of 3 quarters · filed 2023-02-23 | -$533.00K derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$1.21M derived: sum of 2 quarters · filed 2023-02-23 | -$533.00K derived: sum of 3 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 | $2.81M 10-K · filed 2021-02-25 |
| 2020-09-30 | $638.00K 10-Q · filed 2020-11-05 | $1.31M derived: sum of 2 quarters · filed 2020-11-05 | $1.85M 10-Q · filed 2020-11-05 | $2.13M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2020-06-30 | $675.00K 10-Q · filed 2020-07-30 | $1.21M 10-Q · filed 2020-07-30 | $1.50M derived: sum of 3 quarters · filed 2021-02-25 | $1.89M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2020-03-31 | $533.00K 10-Q · filed 2020-04-30 | $820.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.21M derived: sum of 3 quarters · filed 2021-02-25 | $1.52M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-12-31 | $287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $680.00K derived: sum of 2 quarters · filed 2021-02-25 | $983.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.32M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $393.00K 10-Q · filed 2020-11-05 | $696.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.03M 10-Q · filed 2020-11-05 | $1.73M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $303.00K 10-Q · filed 2020-07-30 | $637.00K 10-Q · filed 2020-07-30 | $1.34M derived: sum of 3 quarters · filed 2021-02-25 | $2.03M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $334.00K 10-Q · filed 2020-04-30 | $1.04M derived: sum of 2 quarters · filed 2021-02-25 | $1.73M derived: sum of 3 quarters · filed 2021-02-25 | $1.73M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $702.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.40M derived: sum of 2 quarters · filed 2021-02-25 | $1.40M derived: sum of 3 quarters · filed 2021-02-25 | $1.40M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $695.00K 10-Q · filed 2019-10-31 | $695.00K derived: sum of 2 quarters · filed 2019-10-31 | $695.00K 10-Q · filed 2019-10-31 | $695.00K derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | $0.00 derived: sum of 3 quarters · filed 2020-02-19 | $0.00 derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-02 | $0.00 derived: sum of 2 quarters · filed 2020-02-19 | $0.00 derived: sum of 3 quarters · filed 2020-02-19 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $0.00 derived: sum of 2 quarters · filed 2020-02-19 | $0.00 10-K · filed 2020-02-19 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |